Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ebeling

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Nature Communications|May 26, 2018
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo Garcia-Lopez, Francesca Tessaro, Hendrik R A Jonker, et al.
Cell|September 3, 2013
The CRTC1-SIK1 pathway regulates entrainment of the circadian clockAarti Jagannath, Rachel Butler, Sofia I H Godinho, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes ComplicationsSanthosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, et al.
Cell Death & Disease|February 27, 2026
STING activation induces polarized cytokine secretion of IFN-β and IL-17A promoting photoreceptor death and choroidal disruption in age-related macular degenerationChao Huang, Vishnu Suresh Babu, Sridhar Bammidi, et al.
Nature Communications|April 12, 2023
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle constructAlexandra Gehrlein, Vinod Udayar, Nadia Anastasi, et al.
Journal of Medicinal Chemistry|July 26, 2018
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)Hasane Ratni, Martin Ebeling, John Baird, et al.
Nature Communications|November 15, 2017
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiersManaswini Sivaramakrishnan, Kathleen D McCarthy, Sébastien Campagne, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Nature Communications|May 26, 2018
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo Garcia-Lopez, Francesca Tessaro, Hendrik R A Jonker, et al.
Cell|September 3, 2013
The CRTC1-SIK1 pathway regulates entrainment of the circadian clockAarti Jagannath, Rachel Butler, Sofia I H Godinho, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes ComplicationsSanthosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, et al.
Cell Death & Disease|February 27, 2026
STING activation induces polarized cytokine secretion of IFN-β and IL-17A promoting photoreceptor death and choroidal disruption in age-related macular degenerationChao Huang, Vishnu Suresh Babu, Sridhar Bammidi, et al.
Nature Communications|April 12, 2023
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle constructAlexandra Gehrlein, Vinod Udayar, Nadia Anastasi, et al.
Journal of Medicinal Chemistry|July 26, 2018
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)Hasane Ratni, Martin Ebeling, John Baird, et al.
Nature Communications|November 15, 2017
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiersManaswini Sivaramakrishnan, Kathleen D McCarthy, Sébastien Campagne, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 7